Tagged with “Onsolis”

FDA Approves Cancer Breakthrough Pain Drug with Safeguards

The Food and Drug Administration has approved a new opiate drug for severe breakthrough cancer pain. However, Onsolis® will only be available through a restricted distribution program.

As part of an FDA-required Risk Evaluation and Mitigation Strategy, or REMS, only health care providers, pharmacies, and patients registered with the FOCUS program will be able to prescribe, dispense, and use the medicine. Continue reading…

Posted by Kate Murphy on July 16th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: cancer pain, fentanyl, Onsolis

Search C3

Win Tickets to the US Open Series

Make a donation to the Colorectal Cancer Coalition before Aug 5th for a chance to win tickets to the US Open Series in the following cities: Washington, DC; San Diego, CA; Cincinnati, OH; and New Haven, CT.

Donate and enter!

Good luck!

Sweepstakes ends on Thursday, August 5. Click here for official rules.

Follow C3

Join us on Facebook

Watch us on YouTube

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.